Has Victor Plavner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,136 in general payments to Victor Plavner, MD across 676 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Victor Plavner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Victor Plavner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Victor Plavner, MD

Family Medicine · Arnold, MDNPI 1104818004

Payments from drug & device makers

$16,136in general payments, 2019–2025

Across 676 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
Eisai Inc.$3K
Novo Nordisk$2K
AstraZeneca$1K
Pfizer$1K
Lilly USA, LLC$693
plus $6K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	145	$2,859
Eisai Inc.	8	$2,589
Novo Nordisk	126	$2,177
AstraZeneca	40	$1,243
Pfizer	55	$1,022
Lilly USA, LLC	46	$693
GSK	24	$595
Amgen	15	$382
Merck	22	$367
Bayer	13	$315
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	18	$301
Boehringer Ingelheim	14	$254
Otsuka America Pharmaceutical, Inc.	7	$237
Amarin Pharma, Inc.	11	$219
Esperion Therapeutics, Inc.	9	$212
Johnson & Johnson(2 entities)	6	$205
Exact Sciences	8	$200
Boston Scientific	3	$188
Astellas Pharma US Inc	7	$125
Medtronic(2 entities)	5	$122
Corium, LLC	4	$118
Abbott	6	$115
Jazz Pharmaceuticals Inc.	6	$113
E.r. Squibb & Sons, L.L.C.	6	$94
Genentech USA, Inc.	6	$93
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$86
Bausch Health US, LLC	4	$82
Novartis	4	$75
Sumitomo Pharma America, Inc.	3	$65
Dexcom, Inc.	2	$61
Optinose US, Inc.	3	$61
Takeda Pharmaceuticals U.S.A., Inc.	3	$51
Sanofi Pasteur Inc.	3	$50
Biohaven Pharmaceutical Holding Company Ltd.	2	$43
Biohaven Pharmaceuticals, Inc.	2	$41
Silk Road Medical, Inc.	1	$41
Ironshore Pharmaceuticals Inc.	2	$38
Gilead	2	$36
Vanda Pharmaceuticals Inc.	2	$35
Microtransponder, Inc.	1	$34
Hikma Pharmaceuticals USA	2	$34
Eyevance Pharmaceuticals LLC	2	$34
Lundbeck LLC	2	$33
Globus Medical	2	$31
VBI Vaccine (delaware) Inc.	2	$29
Madrigal Pharmaceuticals	1	$28
TMS Neurohealth Centers Inc.	1	$23
Phathom Pharmaceuticals, Inc.	1	$23
Atricure, Inc.	1	$22
Kowa Pharmaceuticals America, Inc.	1	$21
Idorsia Pharmaceuticals US Inc	1	$21
Antares Pharma, Inc.	1	$20
Arbor Pharmaceuticals, Inc.	1	$18
Dynavax Technologies Corporation	1	$18
Hologic Sales And Service, LLC	1	$18
Watermark Medical, Inc.	1	$17
Neos Therapeutics, LP	1	$17
Almatica Pharma LLC	1	$17
Cumberland Pharmaceuticals, Inc.	1	$16
Resmed Corp	1	$16

How this compares

$16,136 in reported general payments places this provider in the 95th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$226,126

Medicare patients

697

Services billed

6,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Arnold

John BillonArnold$11K
Stephen OngOxon Hill$5.9M
Stephan BartWoodstock$1.7M
Karen DonaldsonBaltimore$899K
Rajiv DuaColumbia$765K
Greg TampusLutherville Timonium$735K
Louis JacquesBaltimore$522K
Stephanie MellerOxon Hill$518K
Sharon ChungGlen Burnie$333K
Michael ObiefuneBaltimore$291K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →